dermatology brochure v19
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
clavubactin ®<br />
trimacare®<br />
®<br />
marbocare<br />
®<br />
prednicare<br />
amoxycare ®<br />
fungiconazol ®<br />
®<br />
cephacare<br />
cephalexin<br />
Skin Infections<br />
cephacare ® -<br />
knock out skin infections 1 st line<br />
• Highly active against S.pseudintermedius, the pathogen responsible for 90% of pyodermas 1<br />
• Active against a wide range of Gram +ve and Gram -ve bacteria<br />
• S.pseudintermedius susceptibility remains unchanged 2<br />
• Proven efficacy particularly in superficial and deep pyoderma:<br />
“Cephalexin... is considered to be the first-choice antibiotic in the treatment of<br />
superficial pyoderma because it is both extremely effective and very safe...” 3<br />
• Yeast extract flavour improves compliance and will not interfere with meat exclusion diets<br />
• Compact packaging containing blister strips<br />
• Dispensing envelopes (available on request)<br />
Scored tablet for easier,<br />
more accurate dosing<br />
Licensed to double<br />
dose 30mg/kg<br />
Licensed for dogs and cats *<br />
Dosage<br />
15mg/kg bodyweight<br />
twice daily<br />
*50mg tablet licensed for cats.<br />
1. Noli C. and Morris D., Staphylococcal pyoderma, BSAVA Manual of Dermatology (2012) 3rd edition, Chp 33, 173-187. 2. Data from CTDS. 3. Toma S. et al., JSAP (2008) 49, 384-391.
Change language